The global respiratory syncytial virus vaccines market size was estimated at USD 3.51 billion in 2024 and is projected to reach USD 28.39 billion by 2030, growing at a CAGR of 42.17% from 2025 to 2030, due to the rising burden of respiratory syncytial virus (RSV)-related hospitalizations... Read More »
June 2025The U.S. traumatic brain injury biomarkers market size was estimated at USD 409.60 million in 2024, is projected to reach 1,854.73 million by 2033, and is forecasted to grow at a CAGR of 18.8% from 2025 to 2033. The U.S. traumatic brain injury (TBI) biomarkers market is expanding signifi... Read More »
June 2025The global traumatic brain injury biomarkers market size was estimated at USD 1.04 billion in 2024 and is projected to reach USD 4.73 billion by 2033, growing at a CAGR of 18.84% from 2025 to 2033. The market is facing significant growth driven by rising incidents of traumatic brain inju... Read More »
June 2025The U.S. biological safety testing products and services market size was estimated at USD 1.44 billion in 2024 and is expected to grow at a CAGR of 9.88% from 2025 to 2033. The rapid growth of the biopharmaceutical and biotechnology industries in the U.S. is one of the foremost drivers o... Read More »
June 2025The global molecular diagnostics for sexually transmitted diseases (STDs) market size was estimated at USD 3.36 billion in 2024 and is projected to reach USD 6.94 billion by 2030, growing at a CAGR of 8.35% from 2025 to 2033. The increasing incidence of sexually transmit... Read More »
June 2025The global biological safety testing products & services market size was estimated at USD 4.89 billion in 2024 and is projected to reach USD 12.09 billion by 2033, growing at a CAGR of 10.64% from 2025 to 2033. The growing prevalence of target diseases and rising production of next-g... Read More »
June 2025The U.S. molecular diagnostics for sexually transmitted diseases market size was estimated at USD 1.11 billion in 2024 and is projected to grow at a CAGR of 7.60% from 2025 to 2033. The growing burden of sexually transmitted diseases (STDs) across the U.S. is a primary growth driver. Acc... Read More »
June 2025The U.S. STI & vaginitis PCR testing market size was estimated at USD 240.72 million in 2024 and is projected to grow at a CAGR of 8.2% from 2025 to 2030. The increasing prevalence of sexually transmitted infections and growing patient awareness are driving demand for advanced diagno... Read More »
June 2025The global shingles vaccine market size was valued at USD 4.25 billion in 2023 and is projected to grow at a CAGR of 15.3% from 2024 to 2030. Market growth is expected to be driven by factors such as the heightened risk of shingles in individuals aged 60 and above and advancements in hea... Read More »
June 2025The global minimal residual disease testing market size was estimated at USD 2.50 billion in 2024 and is projected to reach USD 4.50 billion by 2030, growing at a CAGR of 10.1% from 2025 to 2030. The market for minimal residual disease (MRD) is driven by rising cancer incidence and preva... Read More »
June 2025The global STI and vaginitis PCR testing market size was estimated at USD 660.97 million in 2024 and is projected to reach USD 1,111.9 million by 2030, growing at a CAGR of 9.21% from 2025 to 2030. This is attributed to the rising global incidence of sexually transmitted and vaginal infe... Read More »
June 2025The global oncology companion diagnostic market size was estimated at USD 5.09 billion in 2024 and is projected to reach USD 8.38 billion by 2030, growing at a CAGR of 9.02% from 2025 to 2030. The growth of the market is attributed to the increasing prevalence of cancer, the growing... Read More »
June 2025The global allergy diagnostics market size was estimated at USD 6.54 billion in 2024 and is projected to reach USD 11.63 billion by 2030, growing at a CAGR of 10.39% from 2025 to 2030. The market is driven by the rising incidence of conditions such as allergic rhinitis, asthma, atopic de... Read More »
June 2025The global predictive biomarkers market size was estimated at USD 24.30 billion in 2024 and is projected to grow at a CAGR of 18.02% from 2025 to 2030. The market is experiencing significant growth driven by several factors such as advancements in genomics and precision medicines, increa... Read More »
May 2025The global autoimmune disease diagnostics market size was estimated at USD 5.72 billion in 2024 and is projected to grow at a CAGR of 6.18% from 2025 to 2030. Increasing prevalence of autoimmune disorders such as type 1 diabetes in newborn babies, coupled with demand for rapid diagn... Read More »
May 2025The global hereditary cancer testing market size was estimated at USD 4,674.0 million in 2024 and is projected to grow at a CAGR of 12.9% from 2025 to 2030. The demand for hereditary cancer testing is expediting due to technological advancements of genetic testing for cancer detection, i... Read More »
May 2025The Canada in vitro diagnostics market size was valued at USD 8.05 billion in 2024 and is projected to witness a CAGR of 4.8% from 2025 to 2030. The increasing prevalence of chronic diseases such as cancer, inflammatory conditions, autoimmune disorders, and infectious diseases is one of ... Read More »
May 2025The global dengue testing market size was estimated at USD 612.53 million in 2024 and is expected to grow at a CAGR of 5.22% from 2025 to 2030, driven by escalating dengue outbreaks, technological advancements, and increased public health initiatives. The 2024 dengue epidemic in Latin Am... Read More »
May 2025The global infectious disease in vitro diagnostics market size was estimated at USD 24,301.6 million in 2024 and is projected to reach USD 28,048.2 million by 2030, growing at a CAGR of 2.5% from 2025 to 2030... Read More »
May 2025The global ATP assays market size was estimated at USD 3.31 billion in 2023 and is projected to grow at a CAGR of 7.9% from 2024 to 2030. This is attributed to the demand for rapid and sensitive detection methods, expanding pharmaceutical and biotechnology research applications, regulato... Read More »
May 2025